-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Sacubitril + Valsartan) in Hypertrophic Cardiomyopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Sacubitril + Valsartan) in Hypertrophic Cardiomyopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Sacubitril + Valsartan) in Hypertrophic Cardiomyopathy Drug Details: Sacubitril and...
-
Sector Analysis
Peak Flow Meters Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Peak Flow Meters Market Report Overview The peak flow meters market size was valued at $24.8 million in 2023. Factors such as the growing awareness of the devices in early diagnosis and monitoring of chronic respiratory diseases will drive the growth of the market. Thus, the peak flow meters market will grow at a CAGR of more than 3% from 2023 to 2033. A Peak Flow Meter is used for the diagnosis and monitoring of diseases such as asthma, and...
-
Product Insights
Ablation Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ablation Equipment Pipeline Market Report Overview An Ablation Equipment is a device used to surgically remove a body tissue. The Ablation Equipment pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Territories ·       The US ·       Europe...
-
Sector Analysis
Heart Failure in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032
Heart Failure Market Report Overview The heart failure market size across the 7MM was valued at $31.9 billion in 2022 and is expected to achieve a CAGR of more than 5% during 2022-2032. The 7MM includes the US, 5EU (France, Germany, Italy, Spain, and the UK), and Japan. GlobalData expects uptake of SGLT2 inhibitors and three first-in-class drugs to be the strongest driver of the total heart failure markets in the 7MM. Heart Failure Market Outlook, 2022-2032 ($ Billion) Buy...
-
Sector Analysis
Heart Failure Epidemiology Analysis and Forecast to 2032
Heart Failure Epidemiology Analysis Report Overview In the 7MM, there were 3,094,817 diagnosed incident cases of heart failure in 2022 and will grow at an AGR of more than 1% during 2022-2032. Heart failure (HF) is a condition characterized by the reduced ability of the heart to pump and/or fill with blood. It is a lifelong condition in which the heart muscle cannot pump enough blood to meet the body’s needs for blood and oxygen. HF is diagnosed through blood...
-
Product Insights
Net Present Value Model: Ranexa
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Ranexa Drug Details Ranolazine (Ranexa, CVT-303,...
-
Product Insights
Net Present Value Model: Entresto
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Entresto Drug Details Sacubitril and Valsartan...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (sacubitril + valsartan)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry (sacubitril + valsartan) Drug Details Sacubitril and Valsartan (Entresto, Neparvis, Uperio, Azmarda, LCZ696, Vymada)...
-
Analyst Opinions
Packaging Insights: Innovation Scenarios in Sustainable Packaging Materials – Winners and losers as packaging markets become more environmentally friendly
"Packaging Insights: Innovation Scenarios in Sustainable Packaging Materials", identifies on-trend and emerging packaging materials to help FMCG maufacturers to adopt successful sustainable & ethic strategies. Sustainable packaging was once a niche that only a small minority of the consumers took a notice of. As a result, a small number of products boasted of how environmentally friendly their packaging was, and few consumers gave this factor any importance when shopping. However, more consumers are now becoming aware of impact that packaging...
-
Sector Analysis
EpiCast Report: Heart Failure – Epidemiology Forecasts to 2026
Heart failure (HF), also referred to as congestive cardiac failure, is a heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic needs of the body. Eventually, without the heart's pumping action to deliver oxygen and nutrient-rich blood to the cells, fatigue, shortness of breath, and coughing results. Even everyday activities such as walking, climbing stairs, or carrying weight can become tedious. To forecast the diagnosed incident cases of HF and diagnosed prevalent...